Skip to content

Clinical trials

Completed Prostatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Status: Completed Country / region: Japan Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20072
20083
20091
20105
20115
20124
20134
20142
20154
20162
20172
20194
20202
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc5
Bayer5
Sanofi5
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan5
AstraZeneca4
Janssen Research & Development, LLC4
Janssen Pharmaceutical K.K.3
Merck Sharp & Dohme LLC3
Bristol-Myers Squibb2
Takeda2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms47
Neoplasm Metastasis3
Bulbo-Spinal Atrophy, X-Linked2
Neoplasms2
Acromegaly1
Breast Neoplasms1
Dumping Syndrome1
Hereditary Sensory and Autonomic Neuropathies1
Melanoma1
Neuroendocrine Tumors1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.